All five nodules harbouring the BRAF V600E mutation were malignant carcinomas, including three classic papillary thyroid carcinomas, one follicular variant papillary carcinoma and one anaplastic thyroid carcinoma concurrent with TERT mutation (Fig. 5). This evidence concerns the gene BRAF and differentiated thyroid carcinoma.